data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Lipocine
(NASDAQ:LPCN)
0.845
0.0248[3.02%]
Last update: 10:46AM
15 minutes delayed
Day High/Low0.84 - 0.85
52 Week High/Low0.71 - 1.89
Open / Close0.84 / -
Float / Outstanding86.2M / 88.5M
Vol / Avg.68.5K / 569.5K
Mkt Cap74.8M
P/E-
50d Avg. Price0.87
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float86.2M

Lipocine (NASDAQ:LPCN), Quotes and News Summary

Lipocine (NASDAQ: LPCN)

Day High/Low0.84 - 0.85
52 Week High/Low0.71 - 1.89
Open / Close0.84 / -
Float / Outstanding86.2M / 88.5M
Vol / Avg.68.5K / 569.5K
Mkt Cap74.8M
P/E-
50d Avg. Price0.87
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float86.2M
Benzinga - May 20, 2022, 11:21AM
Benzinga - May 17, 2022, 8:10AM
Benzinga - May 12, 2022, 10:55AM
Benzinga - May 12, 2022, 8:03AM
Benzinga - May 10, 2022, 3:31PM
Benzinga - May 9, 2022, 8:13AM
Benzinga - Apr 25, 2022, 10:18AM
Benzinga - Apr 25, 2022, 10:16AM
Benzinga - Mar 29, 2022, 11:43AM
Benzinga - Mar 29, 2022, 7:06AM
Benzinga - Mar 29, 2022, 7:06AM
Benzinga - Mar 29, 2022, 5:54AM
Benzinga - Mar 11, 2022, 9:26AM
Benzinga - Mar 10, 2022, 2:02PM
Benzinga - Mar 9, 2022, 8:07AM
Benzinga - Mar 1, 2022, 8:04AM
Benzinga - Feb 3, 2022, 8:05AM
Benzinga - Jan 27, 2022, 8:24AM
Benzinga - Jan 21, 2022, 4:05PM
Benzinga - Dec 22, 2021, 8:03AM
Benzinga - Nov 11, 2021, 3:00PM
Benzinga - Nov 10, 2021, 8:22AM
Benzinga - Nov 4, 2021, 9:05AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.020-0.040 -0.0200
REV2.000M0-2.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Lipocine Questions & Answers

Q
How do I buy Lipocine (LPCN) stock?
A

You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Lipocine's (LPCN) competitors?
Q
What is the target price for Lipocine (LPCN) stock?
A

The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 314.20% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Lipocine (LPCN)?
A

The stock price for Lipocine (NASDAQ: LPCN) is $0.845 last updated Today at June 28, 2022, 2:46 PM UTC.

Q
Does Lipocine (LPCN) pay a dividend?
A

There are no upcoming dividends for Lipocine.

Q
When is Lipocine (NASDAQ:LPCN) reporting earnings?
A

Lipocine’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Lipocine (LPCN) going to split?
A

There is no upcoming split for Lipocine.

Q
What sector and industry does Lipocine (LPCN) operate in?
A

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.